A brain angioma is an abnormal cluster of blood vessels inside the brain. These are vascular malformations, meaning they form during development rather than growing like a tumor. Most are discovered incidentally on brain scans done for other reasons, and many never cause symptoms. When they do, the most common problems are seizures, headaches, and in some cases, bleeding into surrounding brain tissue.
The term “angioma” is used loosely to describe several distinct types of vascular malformations, each with different structures, risks, and treatment considerations. Understanding which type you’re dealing with matters, because the outlook varies dramatically between them.
The Four Types of Brain Vascular Malformations
Brain angiomas fall into four categories based on the kind of blood vessels involved and how blood flows through them.
Cavernous malformations (also called cavernous angiomas or cavernomas) are the type most commonly referred to as brain angiomas. They consist of clusters of thin-walled, balloon-like blood vessels packed tightly together without normal brain tissue between them. Blood moves through them slowly, making them “low-flow” lesions. They’re most often found in the upper part of the brain and are the type most likely to cause seizures.
Arteriovenous malformations (AVMs) are tangles of arteries and veins that connect directly to each other, bypassing the normal capillary network that usually sits between them. This creates a high-pressure, high-flow system. AVMs carry the highest bleeding risk of all brain vascular malformations, with hemorrhage being the first sign in up to 50% of cases.
Developmental venous anomalies (DVAs) are the most common type and almost always harmless. They’re essentially unusual arrangements of normal veins that drain healthy brain tissue. Their characteristic appearance on imaging, a cluster of small veins converging into a single larger vein, is often described as a “Medusa head.” DVAs bleed at a rate of only 0.22 to 0.68% per year, and when bleeding does occur near a DVA, it’s usually caused by a nearby cavernous malformation rather than the DVA itself. These are considered “no-touch” lesions that should not be surgically removed, irradiated, or blocked, because they serve as functional drainage pathways for normal brain tissue.
Capillary telangiectasias are tiny clusters of dilated capillaries mixed in with normal brain tissue. They’re found most often in the brainstem, particularly the pons. The vast majority are clinically silent and discovered by accident. In rare cases, depending on their size and location, they can cause dizziness, hearing changes, weakness, or visual symptoms.
Why Cavernous Angiomas Cause Seizures
Cavernous malformations are the type most likely to bring someone to a neurologist, and seizures are the reason in roughly half of symptomatic cases. The mechanism behind this involves slow, repeated micro-bleeds that often produce no obvious symptoms on their own.
Blood moving sluggishly through the malformation’s thin, fragile walls leads to tiny leaks over time. As leaked blood breaks down, it leaves behind iron-containing deposits called hemosiderin along the edges of the lesion. This hemosiderin irritates the surrounding brain tissue, triggering scarring (reactive gliosis) that disrupts the normal electrical signaling of nearby nerve pathways. The result is a seizure focus, a spot in the brain that generates abnormal electrical activity.
This is why, when surgery is performed to treat seizure-causing cavernous angiomas, surgeons aim to remove not just the malformation itself but also the surrounding ring of hemosiderin-stained tissue. Seizure-free outcomes improve when that entire irritated border is taken out.
Bleeding Risk Over Time
For cavernous malformations specifically, the overall annual bleeding rate is about 1% per lesion per year. But that number varies significantly depending on whether the angioma has already caused symptoms. Malformations that first come to attention because of seizures, headaches, or bleeding have an annual hemorrhage rate of about 1.5%. Those found incidentally, with no prior symptoms, bleed at only 0.29% per year.
There’s also a tendency for rebleeding once a first hemorrhage has occurred. Location plays a role too: brainstem cavernous malformations carry higher risks and more serious consequences from bleeding, since even a small hemorrhage in that area can affect vital functions like balance, swallowing, and facial sensation.
AVMs have a different and generally higher risk profile for hemorrhage, which is why they’re managed more aggressively. DVAs and capillary telangiectasias, by contrast, rarely bleed on their own.
How Brain Angiomas Are Found
MRI is the primary tool for detecting brain angiomas. Standard MRI sequences can identify most cavernous malformations, which have a distinctive appearance: a complex central core surrounded by a dark rim caused by hemosiderin deposits.
For detecting smaller or multiple lesions, specialized MRI sequences are more sensitive. A technique called susceptibility-weighted imaging (SWI) is particularly effective because it exploits the magnetic properties of blood products and iron deposits. Older gradient echo sequences were long considered the gold standard, but SWI detects more lesions because it captures three-dimensional, high-resolution images with fewer artifacts near the skull. The older sequences can produce a “blooming” effect where the dark signal from iron deposits spreads and obscures tiny malformations clustered nearby.
This matters most in familial cases, where a person may have dozens of cavernous malformations scattered throughout the brain. Accurate counting and mapping of these lesions helps guide monitoring and treatment decisions.
Familial Versus Sporadic Cases
Most cavernous malformations occur sporadically as a single lesion. But some people inherit a genetic predisposition to develop multiple cavernous angiomas throughout their lives. Familial cavernous malformations follow an autosomal dominant inheritance pattern, meaning a child of an affected parent has a 50% chance of inheriting the mutation.
Three genes are linked to the familial form. Mutations in these genes affect proteins involved in blood vessel stability and cell signaling, leading to the formation of fragile, abnormal vascular channels prone to micro-hemorrhage. People with the familial form typically develop multiple lesions, and new ones can form over time. The presence of multiple cavernous malformations on an MRI, particularly in someone with a family history of seizures or brain hemorrhage, is a strong indicator that genetic testing may be worthwhile.
When Treatment Is Considered
Many brain angiomas, particularly DVAs, capillary telangiectasias, and incidentally discovered cavernous malformations, require no treatment at all. Monitoring over time with periodic MRI scans is the standard approach, though there are no firmly established guidelines on exactly how often imaging should be repeated. Scans are generally more frequent for lesions that have previously bled or grown, and less frequent for stable, asymptomatic ones.
For cavernous malformations that have caused bleeding or neurological symptoms, treatment decisions are made case by case. Key factors include the number and severity of hemorrhages, the location of the lesion, and whether it’s accessible to a surgeon. A cavernous angioma near the brain’s surface is far easier to remove than one buried deep in the brainstem.
Surgical removal is the most definitive treatment when the lesion is reachable. For cavernous malformations in deep or brainstem locations where open surgery carries high risks, focused radiation (stereotactic radiosurgery) is an alternative. In one large study, about 84% of patients who had seizures before radiation treatment achieved good seizure control afterward. Temporary brain swelling occurred in about 3% of treated patients but resolved fully. Worsening of neurological symptoms was rare, affecting roughly 2 to 3% of patients.
Living With a Brain Angioma
For people diagnosed with a cavernous malformation that isn’t being surgically treated, lifestyle factors can influence risk. Controlling high blood pressure is recommended, since elevated pressure may increase the chance of hemorrhage from fragile vessel walls. Binge drinking should be avoided, and tobacco use is discouraged both for general vascular health and for its potential influence on malformation behavior. Some evidence suggests that a diet low in processed foods and emulsifiers may reduce gut permeability, which has emerging connections to cavernous malformation development, though this is a less established recommendation.
People with cavernous malformations and seizures should also be cautious about medications and activities that could lower the seizure threshold, though no rigorous studies have defined exactly which activities pose meaningful risk. Anxiety about the diagnosis is common, and knowing the actual numbers can help put things in perspective: for an incidentally found, asymptomatic cavernous malformation, the annual bleeding risk of 0.29% means that in any given year, there is a greater than 99% chance it will remain stable.